Mettler-Toledo International, Inc. (NYSE:MTD) Stake Lifted by Crossmark Global Holdings Inc.

Crossmark Global Holdings Inc. increased its position in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 10.3% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 3,793 shares of the medical instruments supplier's stock after purchasing an additional 355 shares during the quarter. Crossmark Global Holdings Inc.'s holdings in Mettler-Toledo International were worth $4,479,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Jones Financial Companies Lllp lifted its position in shares of Mettler-Toledo International by 54.9% in the fourth quarter. Jones Financial Companies Lllp now owns 175 shares of the medical instruments supplier's stock valued at $214,000 after acquiring an additional 62 shares in the last quarter. SBI Securities Co. Ltd. purchased a new stake in shares of Mettler-Toledo International in the fourth quarter valued at $33,000. Steward Partners Investment Advisory LLC lifted its position in Mettler-Toledo International by 3.0% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 306 shares of the medical instruments supplier's stock worth $374,000 after buying an additional 9 shares during the period. Assetmark Inc. lifted its position in Mettler-Toledo International by 40.3% during the fourth quarter. Assetmark Inc. now owns 613 shares of the medical instruments supplier's stock worth $750,000 after buying an additional 176 shares during the period. Finally, Proficio Capital Partners LLC purchased a new position in Mettler-Toledo International during the fourth quarter worth about $163,216,000. 95.07% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on MTD shares. UBS Group upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and reduced their target price for the stock from $1,530.00 to $1,350.00 in a research report on Tuesday, May 20th. Jefferies Financial Group upgraded Mettler-Toledo International from an "underperform" rating to a "hold" rating and dropped their price target for the stock from $1,200.00 to $1,110.00 in a research note on Monday, May 5th. Wall Street Zen lowered Mettler-Toledo International from a "buy" rating to a "hold" rating in a research note on Monday, May 5th. Bank of America increased their target price on Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the company a "neutral" rating in a research note on Thursday, June 26th. Finally, Barclays started coverage on Mettler-Toledo International in a research note on Tuesday, June 24th. They issued an "overweight" rating and a $1,325.00 target price for the company. Seven investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat, the company has an average rating of "Hold" and a consensus price target of $1,280.90.

Mettler-Toledo International Stock Down 1.0%

Shares of MTD traded down $12.63 during trading on Friday, reaching $1,223.62. The company's stock had a trading volume of 118,779 shares, compared to its average volume of 150,229. The company has a fifty day moving average of $1,162.86 and a two-hundred day moving average of $1,195.79. Mettler-Toledo International, Inc. has a twelve month low of $946.69 and a twelve month high of $1,546.93. The company has a market cap of $25.43 billion, a price-to-earnings ratio of 30.51, a P/E/G ratio of 3.75 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.90 by $0.29. Mettler-Toledo International had a negative return on equity of 556.22% and a net margin of 22.17%. The company had revenue of $883.74 million for the quarter, compared to analyst estimates of $876.61 million. During the same period in the prior year, the company posted $8.89 EPS. Mettler-Toledo International's quarterly revenue was down 4.6% on a year-over-year basis. As a group, equities analysts forecast that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Insider Buying and Selling at Mettler-Toledo International

In other news, Director Michael A. Kelly sold 1,062 shares of the business's stock in a transaction that occurred on Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total value of $1,231,845.66. Following the completion of the sale, the director directly owned 120 shares in the company, valued at approximately $139,191.60. The trade was a 89.85% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 1.94% of the company's stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.